Validation of SeptiCyte RAPID to Discriminate Sepsis From Noninfectious Systemic Inflammation in Critically Ill Children

From the Pediatric Critical Care Medicine article

Conclusions: SeptiCyte RAPID demonstrated similar performance characteristics in children to that previously reported for adults. Additional real world effectiveness studies are warranted to determine real-time clinical utility, patient benefits, and health economic impact.

Source: Pediatric Critical Care Medicine on PubMed

Leave a Comment